Cartesian Therapeutics, Inc. Adjustments to Additional Paid in Capital, Other
Cartesian Therapeutics, Inc. (RNAC) reported Adjustments to Additional Paid in Capital, Other of $79.00 thousand for the 3-month period ending 2022-06-30, per its 10-Q filed 2023-11-13.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2023-11-13
- Cartesian Therapeutics, Inc. adjustments to additional paid in capital, other for the quarter ending 2022-06-30 was $79.00K.
- Cartesian Therapeutics, Inc. adjustments to additional paid in capital, other for the quarter ending 2022-03-31 was -$79.00K.
- Cartesian Therapeutics, Inc. adjustments to additional paid in capital, other for the quarter ending 2020-09-30 was -$133.00K.
- Cartesian Therapeutics, Inc. adjustments to additional paid in capital, other for the quarter ending 2020-03-31 was -$147.00K.
- Cartesian Therapeutics, Inc. adjustments to additional paid in capital, other for fiscal 2020 was -$370.00K.
| Period end | Adjustments to Additional Paid in Capital, Other 3 month | Adjustments to Additional Paid in Capital, Other 6 month | Adjustments to Additional Paid in Capital, Other 12 month |
|---|---|---|---|
| 2022-06-30 | $79.00K 10-Q · filed 2023-11-13 | $0.00 derived: sum of 2 quarters · filed 2023-11-13 | |
| 2022-03-31 | -$79.00K 10-Q · filed 2023-11-13 | ||
| 2020-12-31 | -$370.00K 10-K · filed 2023-03-02 | ||
| 2020-09-30 | -$133.00K 10-Q · filed 2021-11-09 | ||
| 2020-03-31 | -$147.00K 10-Q · filed 2021-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |